Abstract
Juvenile dermatomyositis is a rare systemic autoimmune disease wth calcinosis as its hallmark sequelae. We report three patients with juvenile dermatomyositis with calcinosis, who were treated with pamidronate. There was complete clearance of calcinosis in one child.
References
Rider LG, Miller FW. Deciphering the clinical presentations, pathogenesis and treatment of the idiopathic inflammatory myopathies. JAMA. 2011;305:183–90.
Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:403–7.
Clara M, Ricardo Y, Luz C. Calcinosis as a complication of juvenile dermatomyositis (JDM). Pediatr Rheumatol. 2011;9:P55.
Marco Puche A, Calvo Penades I, Lopez Montesinos B. Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis. Clin Exp Rheumatol. 2010;28:135–40.
Rauch F, Glorieux FH. Osteogenesis imperfect. Lancet. 2004;24:1377–85.
Martillotti J, Moote D, Zemel L. Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis. Pediatr Radiol. 2014;44:115–8.
Acknowledgments
Prof. MR Nayak, Honorable President, Siksha’O’ Anusandhan (Deemed to be) University and Mr Somadatta Das, Central Research Laboratory, IMS & SUM Hospital for technical support in submitting the manuscript.
Funding
Funding: None
Author information
Authors and Affiliations
Contributions
Contributors: SG: collected data and drafted the manuscript; JRP, MD and MP: diagnosed the case, and planned the management. All authors approved the final version of manuscript.
Corresponding author
Ethics declarations
Competing interest: None stated.
Rights and permissions
About this article
Cite this article
Giri, S., Parida, J.R., Dash, M. et al. Pamidronate in Treatment of Calcinosis in Juvenile Dermatomyositis. Indian Pediatr 57, 75–76 (2020). https://doi.org/10.1007/s13312-020-1712-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-020-1712-2